论文部分内容阅读
目的分析儿童肺炎支原体感染的临床特点。方法对确诊肺炎支原体肺炎的86例儿童病例进行回顾性分析,总结支原体肺炎的临床特点及并发症特点及治疗效果。结果经阿奇霉素治疗,全部发热病儿用药3～5天后体温恢复正常,平均4.2天退热,4～7天后咳嗽症状明显改善,肺部啰音消失,疗程结束后呼吸道症状基本消失。8周后复查MP-IgM,其中阴转65例(75.58%),仍呈阳性21例(24.42%)。12周后复查,阳性患者中18例转阴,仍有3例(3.49%)阳性患者,均无临床症状。结论肺炎支原体是小儿肺炎重要病原,且患儿有年轻化趋势。支原体肺炎有肺外多系统并发症可能。大环内酯类(阿奇霉素)对支原体肺炎疗效明显。
Objective To analyze the clinical features of Mycoplasma pneumoniae infection in children. Methods A retrospective analysis of 86 children diagnosed with Mycoplasma pneumoniae pneumonia was conducted. The clinical features, complications and therapeutic effects of mycoplasma pneumonia were summarized. The results of azithromycin treatment, all fever sick children medication 3 to 5 days after the body temperature returned to normal, an average of 4.2 days fever, cough symptoms improved significantly after 4 to 7 days, pulmonary rales disappeared after the end of the course of respiratory symptoms disappeared. MP-IgM was reviewed after 8 weeks, of which 65 (75.58%) were negative and 21 were still positive (24.42%). 12 weeks after the review, positive patients 18 cases of negative, there are still 3 cases (3.49%) positive patients, no clinical symptoms. Conclusion Mycoplasma pneumoniae is an important pathogen of pneumonia in children, and the trend of younger children. Mycoplasma pneumonia may have multiple extra-pulmonary complications. Macrolides (azithromycin) obvious effect on mycoplasma pneumonia.